Cargando…

Sex differences in heart failure with preserved ejection fraction: From traditional risk factors to sex-specific risk factors

Heart failure with preserved ejection fraction has a higher prevalence in women versus men. There are several proposed mechanisms to explain this sex discrepancy including differences in cardiovascular adaptation to comorbidities and potential underlying etiologic mechanisms. In this review, we summ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaur, Gurleen, Lau, Emily
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Cardiovascular and Metabolic Bone Health in Aging Women
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720805/ https://www.ncbi.nlm.nih.gov/pubmed/36448661 http://dx.doi.org/10.1177/17455057221140209

Ejemplares similares

Age and Sex Differences in Heart Failure With Preserved Ejection Fraction
por: Kobak, Kamil Aleksander, et al.
Publicado: (2022)

Sex Differences in Heart Failure With Preserved Ejection Fraction
por: Sotomi, Yohei, et al.
Publicado: (2021)

Skeletal consequences of heart failure
por: Bandeira, Francisco, et al.
Publicado: (2022)

Romosozumab for the treatment of osteoporosis in women: Efficacy, safety, and cardiovascular risk
por: Lim, Sian Yik
Publicado: (2022)

Sex differences in risk factors, treatment, and prognosis in acute stroke
por: Dahl, Solveig, et al.
Publicado: (2020)

Cardiovascular benefits and risks associated with calcium, vitamin D, and antiresorptive therapy in the management of skeletal fragility
por: Kittithaworn, Annop, et al.
Publicado: (2023)

The Prognostic Significance of Diabetes and Microvascular Complications in Patients With Heart Failure With Preserved Ejection Fraction
por: Sandesara, Pratik B., et al.
Publicado: (2018)

Weight Change and Mortality Risk in Heart Failure With Preserved Ejection Fraction
por: Huang, Peisen, et al.
Publicado: (2021)

Heart failure with preserved ejection fraction: Calculating the risk of future heart failure events and death
por: Schrutka, Lore, et al.
Publicado: (2022)

Metabolic bone health considerations in giant cell arteritis and polymyalgia rheumatica
por: Low, Candice, et al.
Publicado: (2023)

Cardiovascular disease and bone health in aging female rheumatic disease populations: A review
por: Cabling, Marven G, et al.
Publicado: (2023)

Review of bone health in women with estrogen receptor–positive breast cancer receiving endocrine therapy
por: Malagrinò, Matteo, et al.
Publicado: (2023)

Association between vitamin D and cardiovascular health: Myth or Fact? A narrative review of the evidence
por: Ahmadieh, Hala, et al.
Publicado: (2023)

The interplay between bone and heart health as reflected in medication effects: A narrative review
por: Trost, Susanne, et al.
Publicado: (2023)

An overview of the management of osteoporosis in the aging female population
por: Amin, Usman, et al.
Publicado: (2023)

From fragility to resilience: Advancing early identification and management of osteoporosis in post-menopausal women
por: Suvvari, Tarun Kumar, et al.
Publicado: (2023)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
por: Zeng, Heng, et al.
Publicado: (2019)

Sex Differences in Characteristics and Outcomes in Elderly Heart Failure Patients With Preserved Ejection Fraction: A Post-hoc Analysis From TOPCAT
por: Sun, Jiaxing, et al.
Publicado: (2021)

Interatrial Shunt Device for Heart Failure With Preserved Ejection Fraction
por: Kaye, David M., et al.
Publicado: (2019)

Rationale for the Use of Pirfenidone in Heart Failure With Preserved Ejection Fraction
por: Graziani, Francesca, et al.
Publicado: (2021)

Sex differences in circulating proteins in heart failure with preserved ejection fraction
por: Stienen, Susan, et al.
Publicado: (2020)

The role of cardiac magnetic resonance imaging in the assessment of heart failure with preserved ejection fraction
por: Lau, Clement, et al.
Publicado: (2022)

Association Between Arterial Stiffness and Heart Failure With Preserved Ejection Fraction
por: Chi, Chen, et al.
Publicado: (2021)

Diving Into the Diagnostic Score Algorithms of Heart Failure With Preserved Ejection Fraction
por: Abramov, Dmitry, et al.
Publicado: (2021)

Heart failure with preserved ejection fraction—Out with the old and out with the new?
por: Tolento Cortes, Luis, et al.
Publicado: (2022)

Skeletal muscle phenotypic switching in heart failure with preserved ejection fraction
por: Saw, Eng Leng, et al.
Publicado: (2022)

Sympathetic and hemodynamic responses to exercise in heart failure with preserved ejection fraction
por: Manabe, Kazumasa, et al.
Publicado: (2023)

Inflammation as a therapeutic target in heart failure with preserved ejection fraction
por: Peh, Zhen Hui, et al.
Publicado: (2023)

Estimated Glomerular Filtration Rate Is Associated With an Increased Risk of Death in Heart Failure Patients With Preserved Ejection Fraction
por: Chen, Zhuo, et al.
Publicado: (2021)

FRI675 Higher FSH Level Is Associated With Increased Risk Of Incident Hip Fracture In Older Adults, Independent Of Sex Hormone Levels
por: Koh, Eileen H, et al.
Publicado: (2023)

Sex and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Clinical Studies
por: Tadic, Marijana, et al.
Publicado: (2019)

The Potential Therapeutic Role of Celastrol in Patients With Heart Failure With Preserved Ejection Fraction
por: Ajmal, Maryam, et al.
Publicado: (2021)

Gut Microbiota in Heart Failure Patients With Preserved Ejection Fraction (GUMPTION Study)
por: Huang, Ziyin, et al.
Publicado: (2022)

Association of Body-Weight Fluctuation With Outcomes in Heart Failure With Preserved Ejection Fraction
por: Li, Yi, et al.
Publicado: (2021)

Advances in Multimodality Cardiovascular Imaging in the Diagnosis of Heart Failure With Preserved Ejection Fraction
por: Del Torto, Alberico, et al.
Publicado: (2022)

Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF)
por: Valero-Muñoz, María, et al.
Publicado: (2022)

C-reactive protein and statins in heart failure with reduced and preserved ejection fraction
por: Park, Jin Joo, et al.
Publicado: (2022)

Lipotoxicity: a driver of heart failure with preserved ejection fraction?
por: Leggat, Jennifer, et al.
Publicado: (2021)

Impact of Sex in Left Atrial Indices for Prognosis of Heart Failure with Preserved Ejection Fraction
por: Hoshida, Shiro, et al.
Publicado: (2022)

Distinct features of calcium handling and β‐adrenergic sensitivity in heart failure with preserved versus reduced ejection fraction
por: Kilfoil, Peter J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nlu5sg6a5hd0j8ikpgp7517b44